Metrics
- Price
- $2.50
- Market Cap $M
- 330
- Rel Volume
- 0.49
- Vol Up 2W
- 44.40%
- Vol Trend 2W
- -29.80%
- 1D
- +5.04%
- 1W
- +1.21%
- 1M
- +4.17%
- 1M Slope
- +0.28%
- 6M Range
- 59.24%
- Score
- 68.3
- Sharp
- -4.1
Volume
Profile
Inhibikase Therapeutics develops small-molecule therapeutics aimed at treating neurological and infectious diseases, with a focus on kinase inhibition.
Biotech
Pharmaceuticals
Healthcare